SUBSCRIBE
SUBSCRIBE

Aktis Oncology, Inc.

NEWS
Pictured: Eli Lilly Campus in San Diego
Business
Lilly Inks Potential $1.1B Radiopharma Deal with Aktis Oncology
Eli Lilly is paying $60 million upfront to Aktis Oncology to discover and develop novel tumor-targeting radiopharmaceuticals, as radiopharma dealmaking continues to heat up in 2024.
May 21, 2024
 · 
2 min read
 · 
Kate Goodwin
Business
BioSpace Movers & Shakers, Jan. 21
Biopharma and life sciences companies made numerous appointments this week to boards and executive teams. These Movers & Shakers will position the companies for future growth.
January 20, 2022
 · 
8 min read
 · 
Alex Keown
IN THE PRESS
Press Releases
Aktis Oncology to Participate in Upcoming September 2025 Investor Conferences
September 10, 2025
 · 
2 min read
Press Releases
Aktis Oncology Appoints Accomplished Life Sciences Industry Veteran Mike Sherman to its Board of Directors
August 8, 2025
 · 
3 min read
Press Releases
AKTIS ONCOLOGY INITIATES PHASE 1B CLINICAL TRIAL OF ITS NECTIN-4-TARGETING RADIOPHARMACEUTICAL PRODUCT CANDIDATE, AKY-1189, ACROSS MULTIPLE TUMOR TYPES
May 28, 2025
 · 
4 min read
Press Releases
AKTIS ONCOLOGY TO PARTICIPATE IN THE 45th ANNUAL TD COWEN HEALTH CARE CONFERENCE
February 25, 2025
 · 
1 min read
Press Releases
Aktis Oncology Appoints Biotech Industry Veteran Mary Thistle to its Board of Directors
February 4, 2025
 · 
3 min read
Press Releases
Aktis Oncology Announces $175 Million Oversubscribed Series B Financing to Further Advance Its Proprietary Radiopharmaceutical Pipeline
October 1, 2024
 · 
3 min read
Press Releases
AKTIS ONCOLOGY TO PARTICIPATE IN THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE
August 28, 2024
 · 
1 min read
Business
AKTIS ONCOLOGY NAMES TYLER BENEDUM, Ph.D., CHIEF TECHNICAL OFFICER
May 30, 2024
 · 
3 min read
Business
Aktis Oncology Enters Into Strategic Collaboration With Lilly to Discover and Develop Novel Anticancer Radiopharmaceuticals
May 21, 2024
 · 
3 min read
Genetown
Aktis Oncology Announces Presentation at the Oligonucleotide & Peptide Therapeutics (TIDES USA) Conference 2024
May 13, 2024
 · 
1 min read
Load More
JOBS